We previously showed that the intracellular transport of sphingolipids (SLs) is altered in SL storage disease (SLSD) fibroblasts, in part due to the secondary accumulation of free cholesterol. In the present study we examined the mechanism of cholesterol elevation in normal human skin fibroblasts induced by treatment with SLs.
INTRODUCTION
Sphingolipid storage diseases (SLSDs) 1 are metabolic disorders that generally result from a defective lysosomal hydrolase or activator protein leading to accumulation of endogenous lipids in the lysosomes in many different cell types (1). We previously showed that a fluorescent glycosphingolipid (GSL) analog (BODIPY-lactosylceramide;
LacCer) is internalized from the plasma membrane (PM) and transported to the Golgi complex in normal human skin fibroblasts (HSFs), but is mistargeted to endosomes and lysosomes in cells from multiple SLSDs, suggesting a common mechanism of cellular dysfunction in these biochemically distinct diseases (2). In a subsequent study we showed that these SLSD cells accumulate unesterified cholesterol in the late endosomes and lysosomes (3) , and this cholesterol plays an important role in the altered sorting and targeting of the GSL analog in SLSD fibroblasts (3) (4) (5) (6) . Similarly, cholesterol has been reported to accumulate secondary to sphingomyelin storage in sphingomyelinasedeficient (Niemann-Pick A disease) human and mouse cells (7, 8) . The mechanism by which intracellular cholesterol is elevated and/or redistributes in SLSDs with primary defects in SL catabolism is unknown.
In the current study, we show that incubation of normal HSFs with exogenous, naturally occurring SLs resulted in a dramatic increase and redistribution in cellular cholesterol reminiscent of that seen in SLSD cells. These observations led us to further study the relationship between SL accumulation and cellular cholesterol. We provide evidence that accumulation of SLs in endocytic vesicles serves as a molecular trap for cholesterol, binding and immobilizing the sterol as it circulates through the cell.
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Importantly, although the cell has high levels of free cholesterol that can be readily detected by lipid analysis, the protein machinery that regulates cholesterol homeostasis behaves as if cellular cholesterol levels are low. This leads to an induction of sterol regulatory element binding protein (SREBP-1) cleavage, transcriptional activation of the LDL receptor (LDL
EXPERIMENTAL PROCEDURES

Materials
Lipids were obtained from Matreya (State College, PA). Filipin was purchased from Polysciences Inc. (Warrington, Pennsylvania). DiI-LDL was from Intracel (Frederick, MD). Lyso-Lac-S-Cer was synthesized by the Organic Synthesis Core of the Mayo Clinic as described (9) . Lyso-LacCer and Lyso-Lac-S-Cer were N-acylated with BODIPY-fatty acid as described (10) and the corresponding products, BODIPY-LacCer and BODIPY-Lac-S-Cer, were purified by TLC and/or HPLC. Monoclonal antibodies against human EEA1 were from Transduction Laboratories (San Diego, CA). A monoclonal antibody against lysobisphosphatidic acid (LBPA) was a kind gift from Dr.
Toshihide Kobayashi (RIKEN Frontier Research System, Saitama, Japan). Unless otherwise indicated, all other reagents were from Sigma-Aldrich (St. Louis, Missouri).
Cells and cell culture
Normal and SLSD skin fibroblasts were obtained from the Coriell Institute (Camden, NJ) or Human Genetic Mutant Cell repository and cultured in Eagle's MEM (EMEM) plus 10% FBS as described (2, 3, 11) .
Incubation of cells with exogenous SLs
Natural SLs were dissolved in 2:1 ethanol/DMSO to make a 5 mM stock. An aliquot of this stock solution was added to the culture medium (EMEM plus 10% FBS) to make a final concentration of 40 mM SL. The cells were incubated in this medium for various times at 37ºC in a CO 2 incubator. Control cultures were incubated with the same amount of ethanol/DMSO, but containing no SL. Cell viability for each treatment was >90%, as assessed by trypan blue staining. 
Filipin staining
Cells were fixed in 3% formaldehyde in PBS for 30 min followed by incubation in PBS containing 125 mg/ml filipin for 30 min at room temperature (12) . Samples were then observed by fluorescence microscopy (l ex = 360 nm; l em = 460 50 nm).
Analysis of Cholesterol, cholesterol esters, and SLs
Monolayer cultures were grown in 60 mm dishes (70-80% confluency) and scraped in 1 ml of PBS. 100 mL of this suspension was used for protein determination (Bradford protein assay) and the remaining 900 ml was used for quantitation of cholesterol, cholesterol esters, or SLs. Cholesterol and cholesterol esters were extracted as described (13) and the lower organic phase containing these lipids was collected and dried under N 2 . The extracted lipids were then separated by TLC using For SL extraction and analysis (14, 15) , 900 ml of cell suspension (see above) was mixed with 10 ml of pyridine, followed by the addition of 4.5 ml CH 3 OH and 4.5 ml CHCl 3 , and stirring overnight at 40ºC. The sample was then centrifuged for 10 min at 500 xg to remove insoluble cellular debris. The supernatant was collected, dried, resuspended in 900 ml CHCl 3 /CH 3 OH (1:1), and saponified by addition of 100 ml of 0.5 M KOH (stirred for 2 h at 40ºC). After neutralizing with 10 ml of 5 M acetic acid, the Filter sets and exposure times for these double label experiments were selected such that there was no crossover between AlexaFluor 488 CtxB and filipin or blue dextran fluorescence.
Co-localization of cholesterol with EEA1 and LBPA
To study the localization of cholesterol in SL-treated cells, HSF's were incubated with 40 mM bovine globoside in culture medium for 44 hr at 37°C. Cells were then stained with filipin as described above, followed by immunofluorescence using antibodies against EEA1 (labels early endosomes) or LBPA (labels late endosomes) (20) . Fluorescence microscopy and image analysis were performed as described (4, 19) . 
RESULTS
Effect of exogenous SLs on cholesterol in normal HSFs
Cells were incubated with 40 mM bovine LacCer or SM for 44 hr (see Materials and Methods) and the intracellular distribution of cholesterol was examined by filipin staining. Increased filipin fluorescence was observed following incubation with either lipid, relative to untreated control cells (Fig. 1a) . In addition, the pattern of filipin staining was remarkably similar to that seen in various SLSD cell types (3). Similar results to those shown in Fig. 1a , were also obtained when normal HSFs were incubated with C 6 -SM, a short chain non-fluorescent SM analog, or natural globoside or natural rapidly using LacCer than SM. Incubation of HSFs with natural LacCer or SM also resulted in an increase in other classes of SLs (Table 1 ).
The increase in cellular cholesterol upon treatment with exogenous SLs could potentially be due to the formation of SL metabolites. In order to test this, cells were incubated with various concentrations of ceramide (Cer; 5-15 mM), lyso-LacCer (50 mM), gluco-psycosine (50 mM), or psycosine (50 mM) for 44 hr. These treatments had no effect on cellular cholesterol levels as determined by filipin staining or lipid extraction and analysis (data not shown).
Exogenous SLs increase LDL-cholesterol uptake in HSFs
The cholesterol increase in SL treated cells could be due to an increase in the 
Accumulation of endogenous GlcCer induces cholesterol uptake in normal HSFs
To determine whether accumulation of endogenous SLs in normal HSFs also results in an increase in cellular cholesterol, cells were treated with 50 mM CBE, an inhibitor of lysosomal glucocerebrosidase (25), for 24 hr. This resulted in approximately a two fold increase in endogenous GlcCer levels (Table 1) , a dramatic increase in filipin staining ( Fig. 2b) , and approximately a 27% increase in unesterified cholesterol determined by lipid extraction and analysis (Table 1) . On the other hand, when the cells were treated with CBE in medium containing 5% LPDS, there was no change in cellular cholesterol relative to untreated control samples (Fig. 2b) , although CBE treatment in the presence of LPDS still induced approximately a two fold increase in GlcCer (data not shown).
Protein synthesis is required for cholesterol uptake in SL treated cells
To determine whether protein synthesis was required for the elevation in cellular cholesterol induced by exogenous SLs, HSFs were incubated with 40 mM SM for 44 hr in the presence or absence of 17.5 mM cycloheximide, and subsequently fixed and stained using filipin as in Fig. 1 . No increase in filipin staining was observed in the presence of cycloheximide, whereas in the absence of this drug there was a dramatic increase in staining ( Fig. 3a) and approximately a 25% increase in total cellular cholesterol as determined by lipid extraction and analysis. Similar results to those shown in Fig. 3a were obtained using bovine LacCer in place of SM (data not shown). These results demonstrate that protein synthesis is required for the increase in cellular cholesterol which occurs during incubation of HSFs with exogenous SLs.
LDL R expression but not LDL internalization is increased in SL treated cells
We used fluorescent LDL (DiI-LDL) to study the cell surface expression and internalization of the LDL R in HSFs under various conditions. When HSFs were incubated with DiI-LDL at low temperature to bind LDL R at the PM, we observed a 20 to 50% increase in cells treated with SLs for 24 hrs relative to untreated cells (Fig. 3b) . We also quantified the amount of DiI-LDL internalization during 5 min of endocytosis and found an increase of approximately 50% in SL-treated cells relative to control HSFs (Fig.   3b ). This increase in LDL uptake in SL treated cells was most likely due to the increased number of LDL R at the PM since there was little or no difference in the uptake data (relative to controls) after normalization for the number of receptors at the PM (data not shown). To further investigate the increase in LDL R induced by SL treatment we also studied LDL R expression by Western blot analysis. We found a 2-5 fold increase in LDL R expression in cells treated with SLs for 5 hrs relative to control cells depending on the SL used (Fig. 4) . This variation in receptor expression may reflect differences in the elevation of cell associated SLs which varied from a 1.6 to 2.1 fold increase in the treated cells, depending on the SL type (data not shown To investigate the mechanism of upregulation of the LDL R by exogenous SLs we next studied SREBP-1 expression in normal, cholesterol depleted, and SL treated cells.
As shown in Fig. 5a , SREBP was cleaved to the mature 68 kDa fragment (mSREBP)
when HSFs were incubated for 5 hrs with exogenous LacCer, globoside, GM 1 , or SM, similar to that seen when cells were incubated in LPDS medium, while little SREBP-1 cleavage was seen in control samples which were not incubated with exogenous SLs.
Similar results were also obtained using HSFs following a 24 hr treatment with 50 mM CBE to increase endogenous GlcCer (data not shown). These results show that SLs could potentially play an important role in regulating the transcriptional processing of SREBP-1. We also attempted to study the cleavage of SREBP-2; however, using commercial antibodies, we were unable to consistently detect this isoform in our samples. Table 1 shows that Cer levels were elevated in SL treated HSFs. To test the possibility that Cer might activate SREBP-1 cleavage, HSFs were incubated with bovine Cer, C 2 -Cer, C 8 -Cer, or sphingomyelinase under various conditions, however no activation of SREBP was found (data not shown). To further test the possibility that degradation of the exogenous SLs was required for induction of SREBP-1 cleavage, we used a non-degradable analog of LacCer, C 8 -Lac-S-Cer (9, 15) . In preliminary studies we found that incubation of HSFs with C 8 -Lac-S-Cer elevated cellular cholesterol to a similar extent as that seen using bovine LacCer (data not shown). As shown in Fig. 5b , 
SRE-mediated gene transcription and high levels of LDL R in SLSD cells
We previously showed that SLSD fibroblasts have elevated levels of cellular cholesterol (3). Since these cell types also accumulate endogenous SLs (e.g., see Table   2 ), we examined SREBP-1 activation and LDL R expression to determine whether they were similar to normal HSFs incubated with exogenous SLs. As shown in Fig. 6 , there is an enhanced cleavage of SREBP-1 and approximately a 1.5 to 2 fold increase in the levels of LDL R in NPA, NPC, and GM 1 gangliosidosis cell types relative to normal HSFs grown in the presence of 10% FCS. Other SLSD cell types have not yet been studied.
Decreased cholesterol esterification in SL-treated cells
The activation of SREBP-1 in SL-treated cells suggests that even though total cholesterol levels are high, cholesterol is unable to reach the ER pool that regulates SREBP-1 transport to the Golgi apparatus for cleavage. To further test the concept that cholesterol transport to the ER is inhibited in SL-treated cells, we quantified total cholesterol ester and free cholesterol levels in SL-treated cells. In cells incubated with 40
mM bovine globoside in media with 10% FBS for 20 hr, there was >60% decrease in total cholesterol esters compared to untreated controls, with a concomitant increase in free cholesterol ( Table 3) . As expected, in cells incubated with 10% LPDS for 16 h, cholesterol ester levels were significantly reduced for both control and globoside-treated samples. Similar results to those in Table 3 were obtained when cells were incubated with bovine SM or GM 1 in media with 10% FBS for 20 hr or 44 hr (data not shown). in which cells were not incubated with GM 1 , little CtxB staining could be detected and filipin staining was very low relative to HSFs incubated with GM 1 (Fig. 7a, lower panels).
In a related experiment, we also attempted to identify the intracellular compartment which contained the exogenous GM 1 . HSFs were incubated with fluorescent dextran under conditions which result in labeling of the lysosomes (18) . The distribution of GM 1 was then examined by CtxB staining and compared to that of the fluorescent dextran (Fig. 7b) . Using image analysis to quantify the overlap of the two markers (19), we determined that approximately 25% of the GM 1 was in dextran-positive lysosomes.
Finally, we studied the localization of intracellular cholesterol in HSFs incubated with 40 mM bovine globoside as above. As shown in Fig. 8 , only ~5 % of cholesterol- Previous work from our laboratory has shown that GSL analogs, following their integration into the PM, are internalized from the cell surface by a clathrin-independent mechanism involving caveolae (4, 22) . The mechanism(s) by which lipid vesicles or aggregates are internalized is not known.
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Another point of interest with respect to the current study concerns the endocytic compartment(s) in which the exogenous SLs accumulate. In the case of GM 1 , whose distribution can be readily examined using labeled CtxB, we found that there was almost complete colocalization between GM 1 and intracellular cholesterol (Fig. 7a) . However, only ~25% of the lipid accumulated in dextran-stained lysosomes (Fig. 7b) . Finally, we found that in globoside-treated cells, intracellular cholesterol was highly co-localized with the late endosome marker, LBPA (Fig. 8) . These studies show that a significant fraction of both the internalized exogenous SL and cholesterol accumulates in late endosomes and lysosomes.
SL accumulation leads to elevated cholesterol
Incubation of various naturally occurring SLs with normal HSFs over a period of several days resulted in elevated cellular cholesterol ( Fig. 1 ; Table 1 ). As shown in Table   1 , there was an increase in the cell-associated exogenous lipid and cholesterol, relative to untreated control cells, as well as an increase in Cer. To rule out the possibility that a degradation product of the exogenous lipids, rather than the lipid itself, was responsible for the increase in cholesterol, we added various SL breakdown products (psychosine; glucopsychosine; sphingosine; Cer; lyso-LacCer) to HSFs, but no effect on cellular cholesterol levels was seen. Furthermore, addition of the non-degradable LacCer analog, Lac-S-Cer (9,15), also increased cellular cholesterol. There was also an elevation of cellular cholesterol when endogenous glucosylceramide was increased by addition of the glucosylceramidase inhibitor, CBE (Table 1) . Together these results suggest that an excess of SLs, whether derived from exogenous or endogenous sources, induces an increase in cellular cholesterol. At present it is not known whether there is a direct correlation between the amount of SL accumulation and the amount of cholesterol increase (refer to Table 1) . Similarly, the time course for the increase in cholesterol is different for different exogenous lipids as illustrated by the data in Fig. 1b . This could reflect differences in (a) the solubility of the exogenous lipids, (b) lipid uptake mechanisms, (c) SL degradation rates, or a combination of these factors. Finally, our data suggest that the exogenously supplied SLs and cholesterol accumulate in the same endocytic compartments as demonstrated when labeled CtxB and filipin were used to probe the distribution of GM 1 and cholesterol in GM 1 treated cells (Fig. 7a) . The extensive co-localization of these probes in punctate endocytic structures suggests that there may be a direct physical interaction of the accumulated SLs with cellular cholesterol.
Source of elevated cholesterol induced by SLs SL loading increased the binding and internalization of fluorescent LDL (Fig. 3b) and no increase in intracellular cholesterol was seen when SL loading was performed in medium containing LPDS in place of FBS (Fig. 2a) . These results suggest that the majority of the increase in intracellular cholesterol in response to SL loading comes from an increase in the uptake of LDL rather than from de novo synthesis. This conclusion is consistent with our findings that SL loading induced SREBP-1 cleavage and caused a 2.5 to 4.5 fold increase in LDL R protein expression depending on the exogenous SL (Fig. 4) .
Thus, elevation in cellular SLs modulated the transcriptional regulation of the LDL R .
SREBP-1 cleavage was induced by all the exogenous SLs tested, as well as by elevation of endogenous glucosylceramide (by CBE treatment). We recognize that SREBP-1 cleavage should also lead to a stimulation of do novo cholesterol synthesis (27) , although we have not tested this directly. However, since cholesterol did not accumulate in SL treated cells cultured in the absence of LDL, de novo synthesis of cholesterol appears to be insufficient to cause a significant elevation of cholesterol under our experimental conditions. In addition, we note that SREBP cleavage and LDL R expression were increased in three different SLSD cell types, in agreement with the concept that SL accumulation (from uptake of exogenous SLs or from inhibition of SL degradation)
induces an elevation in cholesterol through the LDL pathway. Thus, our studies suggest that SREBP-1 cleavage contributes to elevated cholesterol in SL-treated normal fibroblasts and in SLSD cells.
Cholesterol mobilization and sequestration
How is the accumulation of SLs in endosomal compartments linked to an increase in cholesterol through the LDL R pathway? At first glance this seems paradoxical since cells incubated with SLs have high levels of cholesterol and elevated cholesterol should inhibit LDL R expression (27) . We suggest that the accumulation of SLs in endosomal structures functions as a "molecular trap" for cholesterol, binding and immobilizing cholesterol as it circulates (28) (Table 1) and LDL R expression (Fig. 3b) using different SLs.
Finally we note that incubation of exogenous SLs with HSFs resulted in a significant elevation of Cer (Table 1) , consistent with a previous report (32) .
In the future, it will be of interest to examine the source of the increase in cellular Cer in response to SL loading and the consequences of this elevated Cer. GlcCer accumulation (see Table 1 ) and then stained with filipin as in (a). Note the absence of cholesterol accumulation in both (a) and (b) when incubations were carried out in LPDS. Bars, 10 mm. (NP-C), Niemann Pick, type A (NP-A), or GM 1 gangliosidosis ("GM 1 ") fibroblasts were grown in 10% FBS, washed, lysed, and equal amounts of protein were loaded on gels for determination of (a) SREBP cleavage (as in Fig. 5 ), or (b) LDL R expression levels (as in Fig. 4 ). 
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